Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis

Cited by (427)

Items 101–200 of 427

1. Endotoxin, Endotoxin-Neutralizing-Capacity, sCD14, sICAM-1, and Cytokines in Patients With Various Degrees of Alcoholic Liver Disease
   RENATE URBASCHEK, Robert S. McCuskey, Volker Rudi, Klaus-Peter Becker, Felix Stickel, B. Urbaschek, Helmut Karl Seitz · 2001 · Alcoholism Clinical and Experimental Research
2. Parenteral Nutrition-Associated Cholestasis
   Daniel H. Teitelbaum, Thomas F. Tracy · 2001 · Seminars in Pediatric Surgery
3. Interleukin-10 expression is autoregulated at the transcriptional level in human and murine kupffer cells
   Percy Alexander Knolle, Anja Uhrig, Ulrike Protzer, Martin Trippler, Rainer Duchmann, Karl‐Hermann Meyer zum Büschenfelde, Guido Gerken · 1998 · Hepatology
4. Impaired liver regeneration in mice by lipopolysaccharide via TNF-α/kallikrein–mediated activation of latent TGF-β
   Kuniharu Akita, Masataka Okuno, Masamichi Enya, Shoko Imai, Hisataka Moriwaki, Norifumi Kawada, Yasuhiro Suzuki, Soichi Kojima · 2002 · Gastroenterology
5. Blood pressure regulation by endocannabinoids and their receptors
   Pál Pacher, Sándor Bátkai, George Kunos · 2005 · Neuropharmacology
6. Chasing a ghost? – Issues with the determination of circulating levels of endotoxin in human blood
   Anne Gnauck, Roger Graham Lentle, Marlena C. Kruger · 2016 · Critical Reviews in Clinical Laboratory Sciences
7. Probiotic as a Novel Treatment Strategy Against Liver Disease
   Abbas Ali Imani Fooladi, Hamideh Mahmoodzadeh Hosseini, Mohammad Reza Nourani, Soghra Khani, Seyed Moayed Alavian · 2013 · Hepatitis Monthly
8. The gut microbiome and thromboembolism
   Rida Abid Hasan, Andrew Young Koh, Ayesha N Zia · 2020 · Thrombosis Research
9. Endotoxin and tumor necrosis factor-receptor levels in portal and hepatic vein of patients with alcoholic liver cirrhosis receiving elective transjugular intrahepatic portosystemic shunt
   Jonel Trebicka, Aleksander Ahm Krag, Stefan Gansweid, Beate Appenrodt, Peter Schiedermaier, Tilman Sauerbruch, Ulrich Spengler · 2011 · European Journal of Gastroenterology & Hepatology
10. Endocannabinoid receptor CB2 in nonalcoholic fatty liver disease
    Nahúm Méndez‐Sánchez, Daniel Zamora‐Valdés, Raúl Pichardo-Bahena, Blanca Alicia Barredo-Prieto, Guadalupe Ponciano‐Rodríguez, Luisa Bermejo-Martínez, Norberto Carlos Chávez-Tapia, Héctor Alfredo Baptista González, Misael Uribe · 2006 · Liver International
11. Hepatic Encephalopathy
    Vandana Khungar, Fred F Poordad · 2012 · Clinics in Liver Disease
12. Hyperdynamic Circulation in Cirrhosis: A Historical Perspective
    Walter H. Abelmann · 1994 · Hepatology
13. Acute Reactant Cytokines and Neutrophil Adhesion After Warm Ischemia in Cirrhotic and Noncirrhotic Human Livers
    Pierre‐Alain Clavien, C A Camargo, Reginald M. Gorczynski, Mary Kay Washington, Gary A Levy, B Langer, Paul David Greig · 1996 · Hepatology
14. Apoptosis and Dysregulated Ceramide Metabolism in a Murine Model of Alcohol-Enhanced Lipopolysaccharide Hepatotoxicity
    Ion V. Deaciuc, Mariana Nikolova‐Karakashian, Franco Fortunato, E. Y. Lee, Daniell B. Hill, Craig James McClain · 2000 · Alcoholism Clinical and Experimental Research
15. Norfloxacin Reduces Aortic NO Synthases and Proinflammatory Cytokine Up-Regulation in Cirrhotic Rats: Role of Akt Signaling
    Khalid A. Tazi, Richard Moreau, Philippe Hervé, Agnès Dauvergne, Dominique L. Cazals-Hatem, Frédéric Bert, Odile Poirel, Anne Rabiller, Didier Lebrec · 2005 · Gastroenterology
16. Drug Insight: the role of albumin in the management of chronic liver disease
    Florence Suet-Hing Wong · 2007 · Nature Clinical Practice Gastroenterology & Hepatology
17. Relation of Endotoxin, Endotoxin Binding Proteins and Macrophages to Severe Alcoholic Liver Injury and Multiple Organ Failure
    Hiroshi Fukui · 2005 · Alcoholism Clinical and Experimental Research
18. Microbial metabolism of ethanol and acetaldehyde and clinical consequences
    Mikko P. Salaspuro · 1997 · Addiction Biology
19. Pro- and Anti-Inflammatory Gene Expression in the Murine Small Intestine and Liver After Chronic Exposure to Alcohol
    Sherry D. Fleming, Satoshi Toratani, Terez Shea‐Donohue, Yoshiko Kashiwabara, Stefanie N. Vogel, Eleanor S. Metcalf · 2001 · Alcoholism Clinical and Experimental Research
20. Human Hepatic Stellate Cells Inhibit T-Cell Response Through B7-H1 Pathway
    Charles, Ronald, Chou, Hong-Shiue, Wang, Lianfu, Fung, John J., Lu, Lina, Qian, Shiguang · 2013 · Transplantation
21. Circulating interleukin-1 and tumor necrosis factor antagonists in liver disease
    Herbert Tilg, Wolfgang Vogel, Christian Josef Wiedermann, Leland Shapiro, Manfred Herold, Gert Judmaier, Charles Anthony Dinarello · 1993 · Hepatology
22. MEDIATORS, CYTOKINES, AND GROWTH FACTORS IN LIVER-LUNG INTERACTIONS
    Ralph J. Panos, Steven K. Baker · 1996 · Clinics in Chest Medicine
23. Immune checkpoint receptors: homeostatic regulators of immunity
    Antonio Riva, Shilpa Chokshi · 2018 · Hepatology International
24. Evidence for Normal Nitric Oxide—Mediated Vasodilator Tone in Conscious Rats With Cirrhosis
    Philippe Sogni, Richard Moreau, Masaru Ohsuga, Stéphane Cailmail, Frédéric Oberti, Antoine Hadengue, Eric Pussard, Didier Lebrec · 1992 · Hepatology
25. Membrane receptors on rat hepatocytes for the inner core region of bacterial lipopolysaccharides.
    J B Parent · 1990 · Journal of Biological Chemistry
26. Nitric Oxide: the Elusive Mediator of the Hyperdynamic Circulation of Cirrhosis?
    Brendan J.R. Whittle, Salvador Moncada · 1992 · Hepatology
27. Mechanisms Balancing Tolerance and Immunity in the Liver
    Jan P. Böttcher, Percy Alexander Knolle, Dirk Stabenow · 2011 · Digestive Diseases
28. Mechanisms of endotoxin tolerance in patients with alcoholic liver cirrhosis: role of interleukin 10, interleukin 1 receptor antagonist, and soluble tumour necrosis factor receptors as well as effector cell desensitisation
    V von Baehr, W D Döcke, Mathias Plauth, Christa Liebenthal, S. Küpferling, Herbert Lochs, Renate Baumgarten, Hans‐Dieter Volk · 2000 · Gut
29. Rifaximin Decreases the Incidence and Severity of Acute Kidney Injury and Hepatorenal Syndrome in Cirrhosis
    Tien Sy Dong, Andrew I. Aronsohn, K. Gautham Reddy, Helen S. Te · 2016 · Digestive Diseases and Sciences
30. Defective signal transduction in platelets from cirrhotics is associated with increased cyclic nucleotides
    Giacomo Laffi, Fabio Marra, Paola Failli, Marco Ruggiero, Enrica Cecchi, Vinicio Carloni, A Giotti, Paolo Geñtilini · 1993 · Gastroenterology
31. E5531, a synthetic non‐toxic lipid A derivative blocks the immunobiological activities of lipopolysaccharide
    Tsutomu Kawata, John R. Bristol, Daniel P. Rossignol, Jeffrey Rose, Seiichi Kobayashi, Hiromitsu Yokohama, Akira Ishibashi, William J. Christ, Koichi Katayama, Isao Yamatsu et al. · 1999 · British Journal of Pharmacology
32. Selective intestinal decontamination with norfloxacin reduces bacterial translocation in ascitic cirrhotic rats exposed to hemorrhagic shock
    Josep Maria Llovet, Ramón Bartolí, Ramón Planas, Belén Viñado, J. Perez, Eduard Cabré, J Arnal, Isabel Ojanguren, V. Ausina, Miguel Angel Gassull · 1996 · Hepatology
33. In vivo evidence of enhanced guanylyl cyclase activation during the hyperdynamic circulation of acute liver failure
    Francis Schneider, Philippe Lutun, Karim Boudjéma, Philippe Wolf, J D Tempé · 1994 · Hepatology
34. Control of immune responses by savenger liver endothelial cells
    Percy Alexander Knolle, Andreas Limmer · 2003 · Swiss Medical Weekly
35. Rifaximin Reduces Endotoxemia and Improves Liver Function and Disease Severity in Patients With Decompensated Cirrhosis
    Georgios N. Kalambokis, Epameinondas V. Tsianos · 2011 · Hepatology
36. Role of cannabinoids in chronic liver diseases
    Anna Parfieniuk‐Kowerda, Robert Flisiak · 2008 · World Journal of Gastroenterology
37. Nutritional Support in Alcoholic Cirrhotic Patients Improves Host Defenses
    Sandra Hirsch, María Pía de la Maza, Vivian Gattas, Gladys Barrera, Margarita Petermann, Martín Gotteland, Carlos Muñoz, Marcelo López, Daniel Carlos Bunout · 1999 · Journal of the American College of Nutrition
38. Effects of lactitol on intestinal microflora and plasma endotoxin in patients with chronic viral hepatitis
    Chunlei Chen, Lanjuan Li, Zhongwen Wu, Huguang Chen, Shuzhen Fu · 2006 · Journal of Infection
39. Nlrp3 Activation Induces Il-18 Synthesis and Affects the Epithelial Barrier Function in Reactive Cholangiocytes
    Luca Maroni, Laura Agostinelli, S. Saccomanno, Claudio Pinto, Debora Maria Giordano, Chiara Rychlicki, Samuele De Minicis, Luciano Trozzi, Jesús M. Bañales, Espen Melum et al. · 2016 · American Journal Of Pathology
40. Lipopolysaccharide-neutralizing antibody reduces hepatocyte injury from acute hepatotoxin administration
    Mark J. Czaja, Jun Xu, Yue Ju, Elaine Alt, Phyllis Schmiedeberg · 1994 · Hepatology
41. Opsonophagocytic dysfunction in patients with liver cirrhosis and low responses to tumor necrosis factor-α and lipopolysaccharide in patients’ blood
    Yasuo Ono, Takeshi Watanabe, Kaoru Matsumoto, Tadashi Ito, Otohiko Kunii, Elliot Goldstein · 2004 · Journal of Infection and Chemotherapy
42. TLR-4 Regulates CD8+ T Cell Trapping in the Liver
    Beena John, Ian Nicholas Crispe · 2005 · The Journal of Immunology
43. A Model of Dormant-Emergent Metastatic Breast Cancer Progression Enabling Exploration of Biomarker Signatures
    Amanda M. Clark, Manu P. Kumar, Sarah Wheeler, Carissa L. Young, Raman Venkataramanan, Donna Beer Stolz, Linda Gay Griffith, Douglas A. Lauffenburger, Alan H. Wells · 2018 · Molecular & Cellular Proteomics
44. Endogenous lipoproteins impact the response to endotoxin in humans
    Hobart W. Harris, Jennifer A. Johnson, Stephen J. Wigmore · 2002 · Critical Care Medicine
45. Increased in vitro production and serum levels of the soluble lipopolysaccharide receptor sCD14 in liver disease
    Christian Oesterreicher, Franz Pfeffel, Dagmar Petermann, Christian Müller · 1995 · Journal of Hepatology
46. Intestinal Permeability Is a Mechanical Rheostat in the Pathogenesis of Liver Cirrhosis
    Norihisa Nishimura, Kosuke Kaji, Koh Kitagawa, Yasuhiko Sawada, Masanori Furukawa, Takahiro Ozutsumi, Yukihisa Fujinaga, Yuki Tsuji, Hiroaki Takaya, Hideto Kawaratani et al. · 2021 · International Journal of Molecular Sciences
47. Serum and urinary nitrate levels in liver cirrhosis: endotoxemia, renal function and hyperdynamic circulation
    Bernard Campillo, Phuong Nhi Bories, Christophe Benvenuti, Catherine Dupeyron · 1996 · Journal of Hepatology
48. Modulation of lipopolysaccharide-mediated activation in rat Kupffer cells by antioxidants
    Joseph M. Bellezzo, Karen A. Leingang, Gary A. Bulla, Robert S. Britton, Bruce R. Bacon, Eben S. Fox · 1998 · Journal of Laboratory and Clinical Medicine
49. Differential expression of monocyte chemotactic protein-1 (MCP-1) in transforming rat hepatic stellate cells
    Hans Sprenger, Andreas Kaufmann, Holger Garn, Birgit Lahme, Diethard Gemsa, A Gressner · 1999 · Journal of Hepatology
50. Rifaximin improves thrombocytopenia in patients with alcoholic cirrhosis in association with reduction of endotoxaemia
    Georgios N. Kalambokis, Αthanasia Mouzaki, Maria Rodi, Epameinondas V. Tsianos · 2011 · Liver International
51. Gut Microbiome-based Therapeutics in Liver Cirrhosis: Basic Consideration for the Next Step
    Hiroshi Fukui · 2017 · Journal of Clinical and Translational Hepatology
52. Gut dysbiosis, endotoxemia and clotting activation: A dangerous trio for portal vein thrombosis in cirrhosis
    Francesco Violi, Pasquale Pignatelli, Valentina Castellani, Roberto Carnevale, Vittoria Cammisotto · 2022 · Blood Reviews
53. Presentation of hepatocellular antigens
    Arash Grakoui, Ian Nicholas Crispe · 2016 · Cellular and Molecular Immunology
54. NOD2: a potential target for regulating liver injury
    Mathilde Body–Malapel, Sébastien Dharancy, Dominique D. Berrebi, Alexandre Louvet, Jean‐Pierre Hugot, Dana J. Philpott, Marco Giovannini, Fabrice Chareyre, Gilles Pagès, Emilie Gantier et al. · 2008 · Laboratory Investigation
55. Immunoglobulin A and interleukin 6 form a positive secretory feedback loop: A study of normal subjects and alcoholic cirrhotics
    Jacques M.E. Deviere, Jean Content, Chantal H. Denys, Paul Vandenbussche, Olivier Le Moine, Liliane Schandené, Jean‐Pierre Vaerman, Étienne Dupont · 1992 · Gastroenterology
56. Systemic prostacyclin in cirrhotic patients. Relationship with portal hypertension and changes after intestinal decontamination.
    Carlos Guarner, Germán Soriano, José M. Such, Montserrat Teixidó, Isabel Ramis, Oriol Bulbena, J. Roselló, Francisco Guarner, Emilio Gelpı́, Joaquin Balanzó · 1992 · PubMed
57. Systemic prostacyclin in cirrhotic patients
    Carlos Guarner, Germán Soriano, José M. Such, Montserrat Teixidó, Isabel Ramis, Oriol Bulbena, J. Roselló, Francisco Guarner, Emilio Gelpı́, Joaquin Balanzó et al. · 1992 · Gastroenterology
58. The quest for a vascular endothelial cannabinoid receptor
    George Kunos, Sándor Bátkai, László Offertáler, Fanny Mo, Jie Liu, Jan C. Karcher, Judith Dale Harvey-White · 2002 · Chemistry and Physics of Lipids
59. Liver failure induces a systemic inflammatory response. Prevention by recombinant N-terminal bactericidal/permeability-increasing protein.
    Marja A. Boermeester, Alexander P. J. Houdijk, Sybren Meyer, Miguel A. Cuesta, Ben J. Appelmelk, Robert I. C. Wesdorp, C. Erik Hack, Paul A.M. van Leeuwen · 1995 · Europe PMC (PubMed Central)
60. Progress in Liver Transplant Tolerance and Tolerance-Inducing Cellular Therapies
    Xiaoxiao Du, Sheng Chang, Wenzhi Guo, Shuijun Zhang, Zhonghua Klaus Chen · 2020 · Frontiers in Immunology
61. Portal Vein Thrombosis in Cirrhosis
    Kaiser Raja, Mathew Ollapallil Jacob, Sonal Asthana · 2014 · Journal of Clinical and Experimental Hepatology
62. Differential expression and localization of nitric oxide synthases in cirrhotic livers of bile duct-ligated rats
    Changli Wei, Hoon‐Eng Khoo, Kang-Hoe Lee, Wei‐Min Hon · 2002 · Nitric Oxide
63. Granulocyte Colony-Stimulating Factor Improves Deficient In Vitro Neutrophil Transendothelial Migration in Patients with Advanced Liver Disease
    Carmen Fiuza, Magdalena Salcedo, Gerardo Clemente, José M. Tellado · 2002 · Clinical and Vaccine Immunology
64. Lead enhances lipopolysaccharide and tumor necrosis factor liver injury.
    Ron Honchel, Luis S. Marsano, Donald A. Cohen, Steven I. Shedlofsky, Craig James McClain · 1991 · PubMed
65. Hydrogen sulphide and the hyperdynamic circulation in cirrhosis: a hypothesis
    Mo R. Ebrahimkhani, Ali Reza Mani, Kevin P. Moore · 2005 · Gut
66. Acute endotoxemia following transjugular intrahepatic stent-shunt insertion is associated with systemic and cerebral vasodilatation with increased whole body nitric oxide production in critically ill cirrhotic patients
    Rajiv Jalan, Steven W.M. Olde Damink, J.C. ter Steege, D N Redhead, A. Lee, P.C. Hayes, Nicolaas E.P. Deutz · 2010 · Journal of Hepatology
67. Systemic cytokine response to hepatic resections under total vascular exclusion
    Josep María Badía, Lynne C. Ayton, Thomas J. Evans, Adam J. Carpenter, Ghassan Nawfal, Hannah Kinderman, George Nikolaos Zografos, Shinji Üemoto, Jonathan Cohen, Nagy Adley Habib · 2002 · The European Journal of Surgery
68. Inhibition of DNA synthesis in cultured hepatocytes by endotoxin‐conditioned medium of activated stellate cells is transforming growth factor‐β and nitric oxide‐independent
    Tadahiro Uemura, Chandrashekhar R. Gandhi · 2001 · British Journal of Pharmacology
69. LUNG-LIVER INTERACTIONS IN SEPSIS AND MULTIPLE ORGAN FAILURE SYNDROME
    George M. Matuschak · 1996 · Clinics in Chest Medicine
70. Tumor necrosis factor-alpha decreases hepatocyte bile salt uptake and mediates endotoxin-induced cholestasis
    James F. Whiting, Richard M. Green, A. Rosenblüth, John L. Gollan · 1995 · Hepatology
71. Acute Phase Responses After Acute Liver Injury by Parital Hepatectomy in Rats As Indicators of Cytokine Release
    Robert P. Cornell · 1990 · Hepatology
72. Can immunosuppression be stopped after liver transplantation?
    Pierre‐Alain Clavien, Xavier Muller, Michelle L. De Oliveira, Philipp Dutkowski, Alberto Sanchez Fueyo · 2017 · The Lancet. Gastroenterology & hepatology
73. Elevated resistin levels in cirrhosis are associated with the proinflammatory state and altered hepatic glucose metabolism but not with insulin resistance
    Matthias J. Bahr, Johann Ockenga, Klaus H.W. Böker, Michael Peter Manns, Uwe J.F. Tietge · 2006 · American Journal of Physiology-Endocrinology and Metabolism
74. ALCOHOL AND ENDOTOXIN: ANOTHER PATH TO ALCOHOLIC LIVER INJURY?
    Steven Schenker, Michael K. Bay · 1995 · Alcoholism Clinical and Experimental Research
75. Association of X‐prolyl aminopeptidase 1 rs17095355 polymorphism with biliary atresia in Thai children
    Sarannut Kaewkiattiyot, Sittisak Honsawek, Paisarn Vejchapipat, Voranush Chongsrisawat, Yong Poovorawan · 2011 · Hepatology Research
76. Hypercoagulability in End-stage Liver Disease: Review of Epidemiology, Etiology, and Management
    Thomas A. Verbeek, Jonathan G. Stine, Fuat Hakan Saner, Dmitri S. Bezinover · 2018 · Transplantation Direct
77. Repair after cholestatic liver injury correlates with neutrophil infiltration and matrix metalloproteinase 8 activity
    Mark W. Harty, Hannah M. Huddleston, Elaine F. Papa, Tauquir Puthawala, Aaron P. Tracy, Grant A. Ramm, Stephan Gehring, Stephen H. Gregory, Thomas F. Tracy · 2005 · Surgery
78. Induction of anaphylatoxin C5a receptors in rat hepatocytes by lipopolysaccharide in vivo: Mediation by interleukin-6 from Kupffer cells
    Milena Koleva, Gerald Schlaf, Regine M. Landmann, Otto Götze, Kurt A. Jungermann, Henrike L. Schieferdecker · 2002 · Gastroenterology
79. Increased serum leptin concentrations correlate with soluble tumour necrosis factor receptor levels in patients with cirrhosis
    Shih Yi Lin, Ya Yu Wang, Wayne Huey‐Herng Sheu · 2002 · Clinical Endocrinology
80. Lipopolysaccharides induce Smad2 phosphorylation through PI3K/Akt and MAPK cascades in HSC-T6 hepatic stellate cells
    Ying-Hsien Kao, Po‐Han Chen, Tin-Ya Wu, Yu‐Chun Lin, Ming‐Shian Tsai, Po‐Huang Lee, Tzong-Shyuan Tai, Huoy‐Rou Chang, Cheuk‐Kwan Sun · 2017 · Life Sciences
81. Liver-Lung Interactions in Critical Illness
    George M. Matuschak · 1995 · Update in intensive care and emergency medicine
82. Tumor Necrosis Factor‐α Cell‐Surface Receptors of Liver Parenchymal and Nonparenchymal Cells during Acute and Chronic Alcohol Administration to Rats
    Ion V. Deaciuc, Nympha B. D'Souza, John J. Spitzer · 1995 · Alcoholism Clinical and Experimental Research
83. Chylomicrons alter the hepatic distribution and cellular response to endotoxin in rats
    Hobart W. Harris, Don C. Rockey, Phuonglan Chau · 1998 · Hepatology
84. Toll-Like Receptor 4–Independent Carbon Tetrachloride–Induced Fibrosis and Lipopolysaccharide-Induced Acute Liver Injury in Mice
    Sudhir Kumar, Jiang Wang, Shiva Kumar Shanmukhappa, Chandrashekhar R. Gandhi · 2017 · American Journal Of Pathology
85. Gut–Liver Axis and Inflammasome Activation in Cholangiocyte Pathophysiology
    Luca Maroni, Elisabetta Ninfole, Claudio Pinto, A. Benedetti, Marco Marzioni · 2020 · Cells
86. Low concentrations of ethanol induce apoptosis in human intestinal cells
    K. Asai, Wim A. Buurman, Chris P.M. Reutelingsperger, B. Schütte, Michio Kaminishi · 2003 · Scandinavian Journal of Gastroenterology
87. A pilot study to investigate the use of oxpentifylline (pentoxifylline) and thalidomide in portal hypertension secondary to alcoholic cirrhosis
    Andrew S. Austin, Yashwant R. Mahida, D. Clarke, Stephen D. Ryder, Jan G. Freeman · 2003 · Alimentary Pharmacology & Therapeutics
88. Antigen-Specific Immunotherapy for Treatment of Autoimmune Liver Diseases
    Naomi Richardson, Sky T. H. Ng, David Cameron Wraith · 2020 · Frontiers in Immunology
89. Potential Role of Enhanced Cytokinemia and Plasma Inhibitor on the Decreased Activity of Plasma ADAMTS13 in Patients With Alcoholic Hepatitis: Relationship to Endotoxemia
    Masatoshi Ishikawa, Masahito Uemura, Tomomi Matsuyama, Masanori Matsumoto, Hiromichi Ishizashi, Seiji Kato, Chie Morioka, Masao Fujimoto, Hideyuki Kojima, Hitoshi Yoshiji et al. · 2008 · Alcoholism Clinical and Experimental Research
90. Endotoxin clearance and its relation to hepatic and renal disturbances in rats with liver cirrhosis
    Yoshihiro Nakatani, Hiroshi Fukui, Hiroyuki Kitano, Issei Nagamoto, Tatsuhiro Tsujimoto, Shigeki Kuriyama, Eiryo Kikuchi, Kazushige Hoppou, Tadasu Tsujii · 2001 · Liver International
91. Increased nitric oxide production in the liver in the perioperative period of partial hepatectomy with Pringle's maneuver
    Yasuhiko Sugawara, Keiichi Kubota, Tsutomu Ogura, Hiroyasu Esumi, Kazuto Inoue, Tadatoshi Takayama, Masatoshi Makuuchi · 1998 · Journal of Hepatology
92. Impaired superoxide anion, platelet-activating factor, and leukotriene B4 synthesis by neutrophils in cirrhosis
    Giacomo Laffi, Vinicio Carloni, Elisabetta Baldi, Maria Elisabetta Rossi, Chiara Azzari, Paolo Gresele, Fabio Marra, Paolo Geñtilini · 1993 · Gastroenterology
93. Liver immunity, autoimmunity, and inborn errors of immunity
    Yavuz Emre Parlar, Şefika Nur Ayar, Deniz N Cağdaş, Yasemin Hatice Balaban · 2023 · World Journal of Hepatology
94. Hepatic T-cell senescence and exhaustion are implicated in the progression of fatty liver disease in patients with type 2 diabetes and mouse model with nonalcoholic steatohepatitis
    Byeong Chang Sim, Yea Eun Kang, Sun Kyoung You, Seong Eun Lee, Ha Thi Nga, Ho Yeop Lee, Thi Linh Nguyen, Ji Sun Moon, Jingwen Tian, Hyo Ju Jang et al. · 2023 · Cell Death and Disease
95. Novel immunotherapeutic approaches for hepatocellular carcinoma treatment
    Davide Busato, Monica Mossenta, Lorena Baboçi, Federica Di Cintio, Giuseppe Toffoli, Michele Dal Bo · 2019 · Expert Review of Clinical Pharmacology
96. Pro- and Anti-fibrogenic Functions of Gram-Negative Bacterial Lipopolysaccharide in the Liver
    Chandrashekhar R. Gandhi · 2020 · Frontiers in Medicine
97. Gut‐liver‐axis: Barrier function of liver sinusoidal endothelial cell
    Yang Wang, Yulan Liu · 2021 · Journal of Gastroenterology and Hepatology
98. Blunted cardiac response to hemorrhage in cirrhotic rats is mediated by local macrophage-released endocannabinoids
    Seyed Ali Gaskari, Hongqun Liu, Charlotte D’Mello, George Kunos, Samuel S. Lee · 2015 · Journal of Hepatology
99. DAP12 Promotes IRAK-M Expression and IL-10 Production by Liver Myeloid Dendritic Cells and Restrains Their T Cell Allostimulatory Ability
    Tina L. Sumpter, Vignesh T. Packiam, Heth Roderick Turnquist, Antonino Castellaneta, Osamu Yoshida, Angus W. Thomson · 2011 · The Journal of Immunology
100. Interleukin-6 production by peripheral blood monocytes in patients with chronic liver disease and acute viral hepatitis
     Christian Müller, Christoph Carl Zielinski · 1992 · Journal of Hepatology